Evidence map›Paper›PMID 40277387›Full record

ArticleMicrobiology spectrum2025

Nature of antimicrobial resistance of pathogens causing urinary tract infection in Bangladesh: age and gender profiles.

Ferdous Jahan, Mohammed Anwer

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Biofilm-Mediated Antimicrobial Resistance in PediatricAntibiotics (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ferdous JahanDepartment of Nephrology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Mohammed AnwerDepartment of Physical Sciences, Independent University, Bangladesh (IUB), Dhaka, Bangladesh.ORCID 0000-0001-6007-4173

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the years, the clinical management of urinary tract infections (UTIs) is continuously evolving as a challenge because of resistance to antibiotics. In addition to investigating the nature of antimicrobial resistance to antibiotics, this study will investigate the age and gender nature of patients having these resistances. Patients who were prescribed urine culture sensitivity tests as part of their treatment at a tertiary-level hospital in Dhaka, Bangladesh, were included as a sample. Urine culture was done following the guidelines of CLSI, and a sensitivity test was done following the Kirby-Bauer sensitivity method. About 55% of both males and females have been found to be infected with IMPORTANCE: Because of economic and social practices in Bangladesh, urinary tract infection is a continually evolving disease. The treatment requires relatively updated information about the behavior of the pathogens causing this infection. There is not sufficient information in Bangladesh about the age and gender nature of the infected patients, the infected pathogens, and their antibiotic resistance. Moreover, because of indiscriminate and uncontrolled use of antibiotics within the country, the nature of multidrug resistance of these pathogens is also important for the effective management of these patients. This research attempts to address these issues.

Indexed as

Anti-Bacterial AgentsBacteriaDrug Resistance, BacterialUrinary Tract InfectionsAdolescentAdultAgedAged, 80 and overAge FactorsBangladeshCandidaChildChild, PreschoolDrug Resistance, Multiple, BacterialEscherichia coliFemaleAnti-Bacterial Agentsantibioticsantimicrobial resistanceBangladeshmultidrug resistanceurinary tract infection

Identifiers

PMID40277387
PMCPMC12131805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.